Burlulipase - Nordmark Arzneimittel
Alternative Names: Bacterial lipase; BaLi; Burkholderia bacterial lipase; LU-70274; NM-BL; Project BaLiLatest Information Update: 26 Jun 2019
At a glance
- Originator Nordmark Arzneimittel
- Class Carboxylic ester hydrolases
- Mechanism of Action Enzyme replacements; Triglyceride modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Exocrine pancreatic insufficiency
Most Recent Events
- 26 Jun 2019 No development reported - Phase-II for Exocrine pancreatic insufficiency in USA, Germany (PO)
- 22 Feb 2016 Phase-II development is ongoing in Germany and USA
- 22 May 2013 Phase-I/II clinical trials in Exocrine pancreatic insufficiency in USA (PO)